Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease

Chimeric antigen receptor therapy with reduced cytotoxicity for viral disease

US Patent 11219646 · Granted Jan 11, 2022

Estimated economic value: $5,122,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors with MYD88 and CD40 costimulatory domains2025
Constitutively active cytokine receptors for cell therapy2024
Constitutively active cytokine receptors for cell therapy2024
Human liver chimeric mouse with deficient P450 oxidoreductase2023
Car T-cells recognizing cancer-specific IL 13Ra22023
Cancer gene therapy targeting CD472023
Antibody based gene therapy with tissue-directed expression2023
Antibody based gene therapy with tissue-directed expression2023
Antibody based gene therapy with tissue-directed expression2023
Antibody based gene therapy with tissue-directed expression2023
Immunotherapy of cancer using genetically engineered GD2-specific T cells2016
Tie ring1991